Free Biopharma Daily Stock Updates - 07/02/21
- BPIQ

- Jul 2, 2021
- 1 min read
$XBI $136.56 -1.39%
Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!
COVID Updates
$OCGN -6.90% Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease source
Pipeline Updates
$BCRX +1.29% ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress source
$CYDY 0% CytoDyn Submits Dose Justification Report to FDA to Begin Overcoming Deficiencies in its BLA for HIV source
$ITRM -37.99% Iterum Therapeutics Provides Regulatory Update source
$OBSV -1.34% ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting source $ARWR -25.69% Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study source
$ALEC +52.12% Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases source
$SURE +1.43% uniQure Announces Presentations at Upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress source $ANVS +9.16% Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a Trials source
Financial Updates
$ZNTL -3.44% Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares source
$BSGM -4.14% BioSig Announces Proposed Public Offering of Common Stock source
$CERE -13.86% Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock source $TLSA -4.26% Tiziana Life Science - Distribution Dates: shares and ADRs in Accustem source
$NTLA -4.63% Intellia Therapeutics Announces Closing of $690 Million Public Offering of Common Stock source
Posted by MV


Comments